The partnership with Lovell Government Services is a significant development for Helius Medical Technologies, as it opens up a new and potentially large market for its PoNS device within federal healthcare systems. This development is likely to be viewed positively by investors, as it represents both a revenue opportunity and a validation of the company's technology, thus leading to an increase in stock price.